2111 A randomized, double-blind, placebo-controlled, multicenter Phase II clinical trial of fruquintinib in patients with metastatic colorectal cancer (mCRC). (September 2015) - Li, J.; Xu, R.; Bai, Y.; Xu, J.; Liu, T.; Shen, L.; Wang, L.; Pan, H.; Fan, S.; Hua, Y.; Su, W.; Hugg, C.